$675M sale of Plan B One-Step contraceptive complete

Teva Pharmaceutical Industries Ltd. completed its previously announced $675 million sale of Plan B One-Step and other emergency contraception products to Foundation Consumer Healthcare. Michael McClellan, interim-CFO at Teva, said the deal was part of the company’s ongoing plan to divest “non-core business assets.” Teva (NYSE: TEVA), looking to reduce a heavy debt load, in September sold Paragard, a copper-releasing contraceptive device that is placed in the uterus to prev ent pregnancy for…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - Category: Pharmaceuticals Authors: Source Type: news